Superior Planning, LLC’s BeOne Medicines Ltd ONC Stock Holding History

Superior Planning, LLC’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.3K	Buy	+72	New	+$24.6K	0.01%	592

Other funds holding ONC

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Capital International Inc Los Angeles, California $13.9B AUM 25.98% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Superior Planning, LLC's ONC Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 72 shares worth $26.3K. The stake represents 0.01% of the portfolio and ranks #592 among its holdings.

213 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

Superior Planning, LLC held 72 shares of BeOne Medicines Ltd worth $26.3K as of Q3 2026.
BeOne Medicines Ltd was a new Superior Planning, LLC position in Q3 2026.
BeOne Medicines Ltd made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #592 holding.
213 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.